An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Clinical trial NCT06398080 · WITHDRAWN

Trial details

NCT number: NCT06398080
Sponsor: Regeneron Pharmaceuticals
Status: WITHDRAWN
Study type: OBSERVATIONAL

Neovascular Age-related Macular Degeneration (nAMD)Wet Age-related Macular Degeneration (AMD)Diabetic Macular Edema (DME)Visual Impairment

Start date: 2024-12-12
Primary completion: 2028-01-03
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.